The U.S. Food and Drug Administration (FDA) has updated guidelines for the new coronavirus testing process, which makes the testing process simpler and reduces patient discomfort, while helping to limit the use of personal protective equipment (PPEs) for medical workers — including protective masks, masks, Effects of the supply of gloves and protective clothing.
The change means that participants take their own swabs, while existing procedures require a medical professional to take a swab and collect a sample from the nasal cavity. But the change does not mean that the FDA has made changes to its guidance on taking samples at home — the agency’s rules still explicitly prohibit taking samples at home, as the FDA clarified over the weekend.
Individuals still need to go to authorized clinical or rapid detection points and still need to meet CDC screening requirements. But Vice President Mike Pence said it would mean less consumption of PPE resources and safer testing for front-line medical staff.
Pence added that all countries and private laboratories are now required by law to report their test results to the CDC.